Objective To investigate the effect of recombinant human granulocyte colony-stimulating factor ( rhG-CSF) on acute liver failure ( ALF) induced by D-galactosamine ( D-GalN) in rats. Methods A total of 105 male Sprague-Dawley rats were randomly divided into healthy control group, liver failure model group, and rhG-CSF group, with 35 rats in each group. A rat model of ALF was established by intraperitoneal injection of D-GalN ( 1400 mg/kg) . Alanine aminotransferase ( ALT) level in the liver, total bilirubin ( TBil) , peripheral blood leukocyte count, and liver pathological changes were observed at 12, 24, 48, 72, and 120 hours after modeling, and survival rate was observed at 120 hours after modeling. A one-way analysis of variance was used for comparison of continuous data between multiple groups, and the LST-t test was used for further comparison between two groups. Results Compared with the liver failure model group, the rhG-CSF group had a significantly higher degree of hepatocyte degeneration and necrosis at all time points except 120 hours after modeling, and compared with the liver failure model group at 120 hours after modeling, the rhG-CSF group had better recovery of lobular structure on HE staining. Compared with the liver failure model group, the rhG-CSF group had a tendency of increase in the percentage of cells with positive tumor necrosis factor-α at the five time points after modeling. Compared with the liver failure model group, the rhG-CSF group had significantly higher levels of ALT and TBil at all five time points. Both groups had a significant change in ALT level at 24 hours after modeling ( P < 0. 05) , as well as a significant change in TBil at 24, 48, and 120 hours after modeling ( P < 0. 05) . The rhG-CSF group had a significantly higher peripheral blood leukocyte count than the liver failure model group at all five time points ( all P<0. 120="" .="" there="" was="" no="" significant="" difference="" in="" survival="" rate="" at="" hours="" after="" modeling="" between="" the="" two="" groups="" p="">0. 05) . Conclusion Application of rhG-CSF during the stage of acute inflammatory reaction of ALF may aggravate liver inflammatory response.
[1]LUCIA AP, CHARALAMBOS GA, QUENTIN MA, et al.Role of monocytes and macrophages in experimental and human acute liver failure[J].World J Gastroenterol, 2010, 16 (15) :1811-1819.
|
[2]MARIA JT, MARCELINO A, JESU'S MC, et al.An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure[J].World J Gastroenterol, 2009, 15 (25) :3086-3098.
|
[3]VIEYRA DS, JACKSON KA, GOODELL MA.Plasticity and tissue regenerative potential of bone marrow-derived cells[J].Stem Cell Rev, 2005, 1 (1) :65-69.
|
[4]JANG YY, COLLECTOR MI, BAYLIN SB, et al.Hematopoietic stem cells convert into liver cells within days without fusion[J].Nat Cell Biol, 2004, 6 (6) :532-539.
|
[5]VALFRE DBL, FERRERO I, CRAVANZOLA C, et al.Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine:Engraftment and hepatocyte differentiation versus profibrogenic potential[J].Gut, 2007, 57 (2) :223-231.
|
[6]CASHEN AF, LINK D, DEVINE S, et al.Cytokines and stem cell mobilization for autologous and allogeneic transplantation[J].Curr Hematol Rep, 2004, 3 (6) :406-412.
|
[7]MARK AL, SUN Z, WARREN DS, et al.Stem cell mobilization is life saving in an animal model of acute liver failure[J].Ann Surg, 2010, 252 (4) :591-596.
|
[8]KIMURA M, YAMADA T, IWATA H, et al.Preoperative granulocyte-colony stimulating factor (G-CSF) treatment improves congested liver regeneration[J].J Surg Res, 2010, 158 (1) :132-137.
|
[9]ZHANG L, KANG W, LEI Y, et al.Granulocyte colony-stimulating factor treatment ameliorates liver injury and improves survival in rats with d-galactosamine-induced acute liver failure[J].Toxicol Lett, 2011, 204 (1) :92-99.
|
[10]TERBLANCHE J, HICKMAN R.Animal models of fulminant hepatic failure[J].Dig Dis Sci, 1991, 36 (6) :770-774.
|
[11] TUNON MJ, ALVAREZ M, CULEBRAS JM, et al.An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure[J].World J Gastroenterol, 2009, 15 (25) :3086-3098.
|
[12]YA JC, SHIH LH, YI TL, et al.Gallic acid induces necroptosis via TNF-αsignaling pathway in activated hepatic stellate cells[J].PLo S One, 2015, 10 (3) :e0120713.
|
[13]TOGEL F, ISAAC J, WESTENFELDER C.Hematopoietic stem cell mobilization-associated granulocytosis severely worsens acute renal failure[J].J Am Soc Nephrol, 2004, 15 (5) :1261-1267.
|
[14]KANA S, TAKAAKI O, YU M, et al.Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide[J].J Mol Cell Cardiol, 2010, 49 (3) :469-481.
|
[15]WINSTON S, ASHISH M, SZE YL, et al.G-CSF for stem cell therapy in acute myocardial infarction:Friend or foe?[J].Cardiovasc Res, 2011, 89 (1) :20-30.
|
[16]MAGGIOLINI S, LENATTI L, MALAFRONTE C, et al.G-CSFadministration in acute myocardial infarction:What is the best timing?[J].Cardiovasc Res, 2011, 91 (1) :180-182.
|